der or birth weight on the effects of body composition measures. Conclusions: Our results do not support previous studies showing associations between INS VNTR and IGF1 promoter region polymorphisms with body composition in early childhood.
the IGF1 gene, which is associated with circulating IGF-1 levels, has been suggested to affect birth weight, adult height and the risk of type 2 diabetes [1, [7] [8] [9] [10] [11] . We and others could not replicate an association between variants of the IGF1 promoter region and birth weight [1, 12, 13] . Also, we could not replicate previously suggested associations of this polymorphism with weight gain during infancy [1] .
Both polymorphisms have also been suggested to be associated with various measures of body composition, such as body mass index (BMI), fat mass and waist circumference [1, 3, 5, 11, 14, 15] . To our knowledge, no studies have examined the associations of these common polymorphisms with body composition in infancy and early childhood. It is known that measures of body composition track from early childhood onwards [16] [17] [18] . The genetic component of variations in body composition may be larger in early life when the effects of lifestyle habits may be limited.
Therefore, in addition to our previous reports focused on associations between INS VNTR and IGF1 gene polymorphisms with weight and height in fetal life and early infancy [4, 13] , this study examined in the same prenatally recruited prospective cohort study, the associations of INS VNTR and IGF1 gene polymorphism with different measures of body composition at the ages of 6 weeks and 24 months.
Subjects and Methods

Design
This study was embedded in the Generation R Study, a prospective cohort study from fetal life until young adulthood in Rotterdam, The Netherlands. This study is designed to identify early environmental and genetic determinants of growth, development and health from early fetal life onwards [19, 20] . In total, the cohort includes 9,778 mothers and their children. Additional, more detailed assessments of fetal and postnatal growth and development were conducted in a subgroup of 1,232 parents and their children, referred to as the Generation R Focus cohort. This subgroup is homogeneously ethnic to exclude possible confounding or effect modification by ethnicity. Of all approached women, 80% were enrolled in this subgroup study in late pregnancy (gestational age of 30 weeks). In this subgroup, postnatal examinations were performed at the ages of 6 weeks and 24 months. The study has been approved by the Medical Ethics Committee of the Erasmus Medical Center, Rotterdam. Written informed consent was obtained from all participants or their parents.
Population for Analysis
In total, 1,232 women were enrolled in the Generation R Focus Study. Pregnancies leading to perinatal death (n = 2) were excluded from the present analysis. DNA was collected from cord blood and available for 884 subjects. In total, 744 children were included in this study, of whom genotyping for INS VNTR and IGF1 gene was successful in 738 and 627 children, respectively. Missing cord blood samples were mainly due to logistical and clinical constraints during delivery. Response rates for DNA samples were lower among complicated pregnancies and deliveries.
Genotyping Assays INS VNTR and IGF1 Gene DNA was collected from cord blood samples of the children at birth. For INS VNTR polymerase chain reaction was performed to amplify the -23/ Hph I single nucleotide polymorphism (A/T), which is known to be in almost complete linkage disequilibrium with INS VNTR class [21] . The INS VNTR genotypes were categorized in three classes: I/I, I/III and III/III. INS VNTR is imprinted with the paternally inherited allele being expressed [22] . The I/III heterozygote group can be considered as an indeterminate group, consisting partly of individuals in whom the I allele is expressed and partly of individuals in whom the III allele is expressed. Therefore, although the I/III and III/III genotype groups were both separately compared with the I/I group (reference group), the main interest in our analyses was on the difference between the I/I and the III/III heterozygous subjects.
As for IGF1, polymerase chain reaction was performed using oligonucleotide primers designed to amplify the polymorphic cytosine-adenine repeat 1 kb upstream of the human IGF1 gene as previously described [13, 23] . As in former studies, IGF1 genotypes were categorized in the following categories based on their 192-bp allele: homozygous (wild-type), heterozygous and noncarrier [1, 10, 12, 13, 24] . In both polymorphisms, the genotype distribution was similar to those found in previous studies and the frequency distribution did not deviate from the Hardy-Weinberg equilibrium [1, 3, 9, 25] .
Body Composition
At the ages of 6 weeks and 24 months, all subjects were invited to the research center. Four well-trained medical assistants took all measurements. Anthropometrics were measured without clothes.
Weight was measured to the nearest gram using an electronic scale (Seca ) at 6 weeks of age and a mechanical scale (Seca ) at 24 months of age. Height was measured to the nearest millimeter in supine position using a neonanometer (Holtain Limited ) at the age of 6 weeks and in standing position by a Harpender stadiometer (Holtain Limited ) at the age of 24 months. BMI was calculated as weight/height 2 (kg/m 2 ). At 6 weeks, we calculated ponderal index (weight/height 3 (kg/m 3 )), because this measurement is known to be a better indicator for body composition in newborns than BMI [26] .
Subcutaneous fat mass (mm) was measured by skin fold thicknesses (SFTs), which are valid measurements for use in epidemiological studies [27, 28] . SFTs were measured under standard conditions by using a standard skin fold caliper (SlimGuide; Creative Health Products ). Measurements were taken, as previously described, on the left side of the body at four different sites: triceps, biceps, subscapular and suprailiacal [27] . The consensus between and among observers for the medical assistants was analyzed using the intraclass correlation coefficient (ICC). Intraobserver ICC was 0.88 and interobserver ICC was 0.76 [29, 30] . The skin fold caliper was operated with a constant pressure of 10 g/mm 3 . Total subcutaneous fat mass (TSFM) (mm) was calculated from the sum of triceps SFT + biceps SFT + subscapular SFT + suprailiacal SFT [29] .
Waist circumference was measured at the minimum circumference between the iliac crest and the rib cage and hip circumference was measured at the maximum width over the greater trochanters using a flexible steel tape to the nearest millimeter. Waist-hip ratio (WHR) was then calculated as waist circumference divided by hip circumference.
Covariates
Information on maternal age, parity and weight before pregnancy was obtained by a questionnaire at the enrolment in the study. Maternal smoking habits were assessed in each questionnaire. Maternal height was measured without shoes at our research center. BMI (weight before pregnancy/height 2 ) was calculated. Birth weight, date of birth and gender were obtained from community midwife and hospital registries.
Data Analysis
Power calculation was based on previous studies showing associations of INS VNTR and IGF1 with measures of body composition [1, 3, 5, 9, 14, 15] . With a genotype frequency of 10%, a difference of 0.3 standard deviation can be detected (type I error 5%, type II error 20%, and power 80%). This difference is much smaller than shown in previous studies. Multiple linear regression models were performed to assess the associations of the INS VNTR with BMI, TSFM and WHR at the ages of 6 weeks and 24 months cross-sectionally. These models were adjusted for gender and current age. To take account for differences between observers, we have also adjusted the analyses for the specific observer as covariate. Age, weight, height, BMI and smoking habits of the mother and parity did not change the effect estimates and were therefore not included in the final analyses. Subsequently, we tested the interaction of INS VNTR with gender and birth weight. Similar analyses as for INS VNTR were performed for the IGF1 gene. Additionally, we used a different stratification of genotype groups; presence and absence of 192/194 bp. Recent studies have shown that subjects who were homozygous for the 192-bp or the 194-bp allele had comparable IGF-1 blood levels, while individuals who were homozygous for either alleles shorter than 192 bp or longer than 194 bp had significantly lower serum IGF-1 levels [11, 31, 32] . Therefore, we assumed that all subjects who were homozygous for 192 or 194 bp or were carriers of both the 192-bp allele and the 194-bp allele could be regarded as the wild-type group. Consequently, all subjects who were carriers of at least one variant allele (either less than 192 bp or more than 194 bp) were grouped as variant carriers. All measures of association are presented with their 95% confidence intervals (CI). All statistical analyses were performed using the Statistical Package of Social Sciences version 11.0 for Windows (SPSS, Inc., Chicago, Ill., USA).
Results
A total of 744 subjects were included in the study. Maternal and child characteristics are shown in table 1 , as well is the genotype frequency distribution. The DNA for genotyping of INS VNTR was available in 738 subjects. The IGF1 promoter region was determined in 627 subjects. Gender distribution was similar in the genotype groups for both genes. At 6 weeks, 657 subjects participated in the postnatal assessment, at 2 years this number was 629.
The INS VNTR genotype distribution in this study was 50.4, 40.4 and 9.2% for class I/I, I/III and III/III, re- Values are means (SDS), medians (95% range) for variables with skewed distribution or percentages. Of the total group, data were missing on maternal weight and BMI before pregnancy (n = 127), parity (n = 1) and smoking habits (n = 65). The allele distribution is based on 2 alleles per infant. spectively ( table 1 ) . Differences in BMI, TSFM and WHR between the genotype groups at each age are given in figure 1 . These estimated differences were based on multiple linear regression models and genotype group I/I was used as reference. No statistically significant associations (p 1 0.05) were found with the different measurements of body composition at 6 weeks and 24 months.
Subsequently we looked at the interaction of INS VNTR with gender and birth weight at 6 weeks. We did not find a significant association between these determinants. In table 2 the association of INS VNTR with BMI, TSFM and WHR at 24 months stratified by gender is presented. No significant differences in any measure of body composition between the different genotypes were present in boys or girls.
For the IGF1 gene, 43.1% subjects were 192 bp homozygous, 45.8% were 192 bp heterozygous, and 11.2% subjects were noncarriers. Again no significant differences were observed in the maternal, birth and postnatal characteristics between these three groups. Figure 2 represents the differences in BMI, TSFM and WHR at 6 weeks and 24 months between the IGF1 genotype groups. No differences in body composition were found at any age and no significant association was found in the interac- tion of IGF1 genotype with gender and birth weight at 6 weeks. The association between IGF1 genotype and body composition at 24 months by gender is shown in table 3 . No differences in body composition were found.
Classification of the IGF1 gene promoter polymorphism based on the presence and absence of the 192-/194-bp allele genotypes showed that this genotype was present in 442 (70.5%) and absent in 182 (29.5%) subjects. Again no differences were found in body composition in early childhood between the two groups (data not shown).
There were no differences found in ponderal index at 6 weeks in the variant carriers of INS VNTR (differences: 
Discussion
In this population-based prospective cohort study, the associations between a polymorphism in INS VNTR and in the promoter region of the IGF1 gene and parameters of body composition were investigated. Body composition was measured by BMI, TSFM and WHR. No differences were found in these polymorphisms in relation to body composition.
To our knowledge, this study is the first prospective cohort that examined the association between polymorphisms in the INS VNTR and IGF1 gene and body composition in early childhood. DNA was collected from cord blood and available for 884 subjects. In total, 744 children were included in this study, of whom genotyping for INS VNTR and IGF1 gene was successful in 738 and 627 subjects, respectively. Missing cord blood and DNA samples were mainly due to logistical and clinical constraints during delivery. Response rates for DNA samples were lower among complicated pregnancies and deliveries. As a consequence, children who were not genotyped had a shorter gestational age at birth (difference: -0.49 (95% CI -0.73, -0.25) weeks, p ! 0.01) and a lower birth weight (difference: -108.0 (95% CI -182.1, -0.34.0) grams, p ! 0.01). The numbers of children with low birth weight (n = 12) or preterm birth (n = 25) were lower than expected. Lack of variation in birth weight could lead to an underestimation of the effect. However, previous studies did not consistently show associations between these two genetic variants and birth weight. Measurements of body composition were available in 657 (88%) subjects at 6 weeks and in 629 (85%) subjects at 24 months. Our effect estimates would be biased or underestimated if the associations between INS VNTR and IGF1 genotype and Values are regression coefficients (95% CI) and reflect the difference in body composition. Differences are adjusted for current age. Analyses are based on the following numbers: boys: I/I, n = 129 (45%), I/III, n = 131 (45%) and III/III, n = 30 (10%); girls: I/I, n = 154 (55%), I/III, n = 105 (37%) and III/III, n = 22 (8%). Values are regression coefficients (95% CI) and reflect the difference in body composition. Differences are adjusted for current age. Analyses are based on the following numbers: boys: homozygous, n =107 (43%), heterozygous, n = 108 (44%) and noncarrier, n = 33 (13%); girls: homozygous, n = 97 (40%), heterozygous, n = 120 (50%) and noncarrier, n = 23 (10%).
growth characteristics differ between those with and without complete data. This seems unlikely but cannot be excluded. However, generalization of our results to children born preterm or with low birth weight is limited.
Previous studies have shown a relationship between the INS VNTR genotype and body composition. The class III genotype was associated with larger BMI, body weight, fat mass and waist circumference [3, 5, 14, 15] . These studies concluded that subjects homozygous for the INS VNTR class III allele may have a larger tendency to gain weight through the accumulation of fat, which is closely associated with insulin resistance [15] . Our data however did not show an association between the INS VNTR genotype and different parameters of body composition in early childhood. Our findings are in line with a large German [1] and Finnish [6] study, which also failed to confirm an association between a polymorphism in INS VNTR and body composition. These inconsistent findings are not likely to be explained by ethnic differences in VNTR subclass composition, presence (or absence) of nearby modifying variants, or variable local linkage disequilibrium relationships because these are known to be broadly similar in all non-African populations [21] . Another explanation could be that biological differences between the various study samples (e.g., environmental exposures, antenatal management, secular trends) and/or to study design-related issues (accuracy and choice of measurements of body composition) have an effect on the power to detect VNTR association effects.
In the present study, we did not find an association between INS VNTR and IGF1 gene polymorphisms and different parameters of body composition. These findings are in line with our previous reports, in which we described no association between INS VNTR and IGF1 gene polymorphisms with weight and height at various ages from fetal life until infancy [4, 13] . Landmann et al. [1] found that the absence of the common 192-bp allele of the IGF1 gene is associated with an accelerated weight gain in the first year of life. Vaessen et al. [9] found that the absence of the 192-bp allele was associated with a decreased adult height. In the same cohort, noncarriers had a lower birth weight [10] . These differences could be explained by differences in study design. One of the major strengths of our study is that we examined the association of the IGF1 gene promoter polymorphism with different parameters of body composition rather than, as previously performed, with only birth or postnatal weight. Measurements of body composition give a more complete picture of the distribution of fat mass, because they provide regional data instead of whole body data. Health risks associated with overweight are now known to derive primarily from fat rather than weight [33] . Body composition is therefore a better risk indicator for developing overweight of obesity [34, 35] .
Recently, Voorhoeve et al. [11] examined the association between the IGF1 gene polymorphism and body fatness. They found that body weight, BMI, fat mass, waist circumference and hip circumference were higher in female variant carriers of the IGF1 polymorphism. A similar trend was seen in boys. We could not replicate these findings, even after using the same stratification. This could be explained by the difference in age of the subjects. The subjects in the study of Voorhoeve were between 10.7 and 13.6 years as we examined subjects until the age of 2 years. Furthermore, the subjects of Voorhoeve were born between 1981 and 1989, while our subjects were born between 2003 and 2005. In line with Voorhoeve, we expected that our younger cohort would show a stronger relationship between the IGF1 genotype and body composition, because it is known from recent epidemiological studies that the prevalence of overweight and obesity is increasing worldwide. The discrepancy between our results and the results of Voorhoeve could mean that it takes some time to develop the differences in body composition based on IGF1 genotype. At the age of 2 years, the differences between genotypes are not yet present. It is also possible that the differences between genotypes found by Voorhoeve are significant by chance because they were very small. Thus far, our and previous studies show rather inconsistent associations with growth characteristics in early life. Chance findings cannot therefore be excluded. Further studies in larger cohorts are necessary to study the effect of this IGF1 promoter polymorphism with growth from fetal to early postnatal life.
In conclusion, this study demonstrates that a polymorphism in the INS VNTR and IGF1 gene is not associated with body composition in early childhood. Longer follow-up studies are needed to examine whether and at which age differences develop in body composition between polymorphisms in the INS VTNR and IGF1 genotype. Currently, studies are being performed for further follow-up measurements in our cohort. Also systematic searches for disease-associated common variants by means of genome-wide association studies may enable us to purchase a more complete understanding of the entire IGF1 and VNTR-INS-IGF2 region and its relationship to growth and morbidity in childhood and later life.
